Neuro-Oncology Nugget: Synthetic Super-Enhancer Gene Therapy for Glioblastoma

Podcast Host and Interviewee: Shahad Abdulsahib, PhD Graduate, UT Health San Antonio

Podcast Description: Shahad Abdulsahib discusses a landmark preclinical study evaluating Synthetic Super-Enhancer-based gene therapy for glioblastoma, published in Nature in April 2026, and the rapid translation of these findings into the first-in-human Phase 1/2 ADePT clinical trial with first patient dosing in May 2026.